Baird Financial Group, Inc. Astrazeneca PLC Transaction History
Baird Financial Group, Inc.
- $59 Billion
- Q3 2025
A detailed history of Baird Financial Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Baird Financial Group, Inc. holds 269,161 shares of AZN stock, worth $24.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
269,161
Previous 262,804
2.42%
Holding current value
$24.1 Million
Previous $18.4 Million
12.45%
% of portfolio
0.03%
Previous 0.03%
Shares
34 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...